See how top analysts and institutions rate MLTX — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| H.C. Wainwright | Downgrade | Buy → Neutral | 2025-10-02 | |
| Goldman | Downgrade | Buy → Neutral | $7 | 2025-10-01 |
| Citigroup | Downgrade | Buy → Neutral | $5 | 2025-09-30 |
| Wolfe Research | Downgrade | Outperform → Underperform | $2 | 2025-09-30 |
| BTIG Research | Downgrade | Buy → Neutral | 2025-09-29 | |
| RBC Capital Mkts | Downgrade | Outperform → Sector Perform | $10 | 2025-09-29 |
| Jefferies | Downgrade | Buy → Hold | $8 | 2025-09-29 |
| Stifel | Downgrade | Buy → Hold | $13 | 2025-09-29 |
| Rothschild & Co Redburn | Initiated | Neutral | $65 | 2025-07-28 |
| Wolfe Research | Upgrade | Peer Perform → Outperform | $61 | 2025-05-19 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 1 | 8 | 6 | 2 | 0 |
| October 2025 | 1 | 8 | 6 | 2 | 0 |
| September 2025 | 2 | 8 | 6 | 1 | 0 |
| August 2025 | 3 | 13 | 1 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for MLTX, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
